Recombinant human serum albumin: a true therapeutic substitute or merely a serum level elevator?
Abstract
Translate Article 
Take Notes
Recombinant human serum albumin: a true therapeutic substitute or merely a serum level elevator?
ReferencesShowing 7 of 7 papersComment on "CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study". Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics New frontier in albumin replacement therapy. Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies.
- 10.1007/s12072-025-10912-5
- Sep 15, 2025
- Hepatology international
543
- 10.1002/hep.31884
- Aug 1, 2021
- Hepatology (Baltimore, Md.)
- 10.1007/s12072-025-10871-x
- Jul 23, 2025
- Hepatology international
412
- 10.1016/s0140-6736(18)30840-7
- Jun 1, 2018
- The Lancet
6
- 10.1016/j.xcrm.2023.101345
- Dec 20, 2023
- Cell reports. Medicine
- 10.1136/gutjnl-2025-336092
- Jul 22, 2025
- Gut
- 10.1136/gutjnl-2025-335651
- Jul 25, 2025
- Gut
More from: Hepatology internationalhnRNPA3 promotes the proliferation of hepatocellular carcinoma cells by stabilizing GLI2 proteins and activating Hedgehog pathway. Comment on "Immunomodulation by bepirovirsen may induce killing of infected hepatocytes (B-Together study)". SOX9 promotes hepatocyte proliferation via upregulating TGF-α expression during liver regeneration. Integrating mental health into MASLD prevention. Methodological considerations in linking depression to metabolic dysfunction-associated steatotic liver disease: insights for future study design. Enhancing the understanding and management of metabolic dysfunction-associated steatotic liver disease in colorectal cancer patients: insights and future directions. Author Response to "Letter to the Editor": "Critical flaws in the predictive model for bacterial infections in older AoCLD patients". Depression and MASLD: a shared burden of mind and metabolism. Reply to: A commentary on "Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis". p53 regulates glucose metabolic reprogramming in MASLD-related hepatocellular carcinoma via modulating mitochondrial pyruvate carriers.
- New
- Research Article
- 10.1007/s12072-025-10946-9
- Nov 5, 2025
- Hepatology international
- New
- Discussion
- 10.1007/s12072-025-10952-x
- Nov 4, 2025
- Hepatology international
- New
- Research Article
- 10.1007/s12072-025-10940-1
- Nov 3, 2025
- Hepatology international
- New
- Discussion
- 10.1007/s12072-025-10950-z
- Nov 3, 2025
- Hepatology international
- New
- Discussion
- 10.1007/s12072-025-10948-7
- Nov 1, 2025
- Hepatology international
- New
- Discussion
- 10.1007/s12072-025-10947-8
- Oct 29, 2025
- Hepatology international
- New
- Discussion
- 10.1007/s12072-025-10942-z
- Oct 28, 2025
- Hepatology international
- New
- Front Matter
- 10.1007/s12072-025-10943-y
- Oct 27, 2025
- Hepatology international
- Discussion
- 10.1007/s12072-025-10941-0
- Oct 25, 2025
- Hepatology international
- Research Article
- 10.1007/s12072-025-10939-8
- Oct 25, 2025
- Hepatology international
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.